| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/29/2001 | EP1126854A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 08/29/2001 | EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 08/29/2001 | EP1126849A1 Heterocyclic potassium channel inhibitors |
| 08/29/2001 | EP1126842A2 Inhibition of the formation of vascular hyperpermeability |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP1126832A2 Conductance of improperly folded proteins through the secretory pathway |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310625A Use of alpha1 & beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease |
| 08/29/2001 | CN1310025A Therapeutical compound and its application |
| 08/29/2001 | CN1310011A Medicine for treating kidney damage caused by immunological disease lupus erythematosus |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/28/2001 | US6281252 Administering a aliphatic amine polymer; therapy for kidney stones |
| 08/28/2001 | US6281243 Derivatives of azetidine and pyrrolidine |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/28/2001 | US6280742 Methods and materials for the treatment of prostatic carcinoma |
| 08/28/2001 | CA2042113C Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001060825A1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/23/2001 | WO2001060822A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | WO2001060819A1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 08/23/2001 | WO2001060816A1 Kinase inhibitors |
| 08/23/2001 | WO2001060802A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/23/2001 | WO2001060798A1 Amine derivatives for the treatment of apoptosis |
| 08/23/2001 | WO2001060786A1 Aminoalcohol derivatives |
| 08/23/2001 | WO2001060414A2 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | WO2001060394A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | WO2001060374A1 Use of paullone derivatives for making medicines |
| 08/23/2001 | WO2001060368A1 Inhibitors of prenyl-protein transferase |
| 08/23/2001 | WO2001060358A1 Method and compositions for treating fibrotic diseases |
| 08/23/2001 | WO2001060352A1 Use of alpha 1a adrenoceptor agonists with alpha 1b and alpha 1d antagonism for the treatment of stress urinary incontinence |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001010860A3 Quinazolinone and azaquinazolinone derivatives |
| 08/23/2001 | US20010016661 Indolealkanoic acid derivatives inhibits aldose reductase and useful for treating chronic complication associated with diabetes mellitus including diabetic cataracts, retinopathy, nephropathy and neuropathy |
| 08/23/2001 | US20010016603 Calcium formate for use as a dietary supplement |
| 08/23/2001 | US20010016596 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/23/2001 | US20010016590 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol |
| 08/23/2001 | US20010016586 Use of organic compounds |
| 08/23/2001 | US20010016576 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 08/23/2001 | US20010016346 Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | CA2400860A1 Aminoalcohol derivatives |
| 08/23/2001 | CA2400634A1 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2399822A1 Stable, nasally, orally or sublingually applicable pharmaceutical preparation |
| 08/23/2001 | CA2399147A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
| 08/23/2001 | CA2397768A1 Use of alpha 1a adrenoceptor agonists with alpha 1b and alpha 1d antagonism for the treatment of stress urinary incontinence |
| 08/23/2001 | CA2397651A1 Amine derivatives for the treatment of apoptosis |
| 08/23/2001 | CA2397560A1 Use of paullone derivatives for making medicines |
| 08/22/2001 | EP1125925A1 Amine derivatives for the treatment of apoptosis |
| 08/22/2001 | EP1124855A2 Compositions and methods for treating polycystic kidney disease |
| 08/22/2001 | EP1124845A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 08/22/2001 | EP1124837A2 Novel macrolide antibiotics |
| 08/22/2001 | EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/22/2001 | EP1124814A1 Aromatic derivatives and iron complexes thereof for the use as normalising agents of the iron level |
| 08/22/2001 | EP1124811A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124810A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 08/22/2001 | EP1124779A1 Vitamin d analogues |
| 08/22/2001 | EP1124572A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/22/2001 | EP1124567A2 Buffered compositions for dialysis |
| 08/22/2001 | EP1124548A2 Compositions for the treatment and prevention of cardiovascular diseases |
| 08/22/2001 | EP1124546A2 Use of hyaluronic acid for the treatment of radiation cystitis |
| 08/22/2001 | EP0785926B1 Carboxylic acid derivatives, their preparation and their use as medicaments |
| 08/22/2001 | EP0764204B1 HUMAN OXALYL-CoA DECARBOXYLASE |
| 08/22/2001 | EP0752854B1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 08/22/2001 | EP0697880B1 Inhibition of leukocyte adhesion |
| 08/22/2001 | CN1308941A Medicine for treating prostatitis |
| 08/22/2001 | CN1308939A Ketonic acid preparation for treating nephrosis |
| 08/22/2001 | CN1069829C Percutaneous applied medicine contg. gestodene |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277367 Erythropoietin solution preparation |
| 08/21/2001 | CA2294595C Inhibiting bone resorption |
| 08/21/2001 | CA2207348C Benzimidazole derivatives |
| 08/21/2001 | CA2093793C Alkylidene analogs of 1'-aminospiro¬isoquinoline-4(1h),-3'-pyrrolidine|1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058899A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 08/16/2001 | WO2001058897A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 08/16/2001 | WO2001058895A1 Benzofuran carboxamides and their therapeutic use |
| 08/16/2001 | WO2001058882A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/16/2001 | WO2001058880A1 Novel triazole derivatives |
| 08/16/2001 | WO2001058878A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | WO2001058875A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058452A1 Thermal ablation of tissue |
| 08/16/2001 | WO2001058443A1 TNF- α INHIBITORS |
| 08/16/2001 | WO2001023550A3 Pca3 messenger rna species in benign and malignant prostate tissues |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 08/16/2001 | WO2001009115A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |